Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The serotonin 5-HT4 receptor is a G protein-coupled receptor (GPCR) that binds the neurotransmitter serotonin (5-hydroxytryptamine, or 5-HT). It is encoded by the HTR4 gene. The receptor is a glycosylated transmembrane protein and exists in multiple isoforms. It modulates the release of various neurotransmitters and plays a role in cognition, mood regulation, appetite, and gastrointestinal motility. Agonists targeting this receptor are being explored for cognitive impairment, depression, and gastrointestinal motility disorders.
Agonists stimulate adenylyl cyclase activity and increase intracellular cAMP, leading to enhanced neuronal excitability and increased acetylcholine release.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serotonin 5-hydroxytryptamine 4 Receptor (5-HT4).